The fresh funding will help the biotech startup advance a candidate to treat a genetic disorder, “ATTR-CM,” that has become a battleground for companies like Pfizer, Alnylam and BridgeBio.
Oversubscribed financing led by Frazier Life Sciences with participation from F-Prime, Qiming Venture Partners, SR One and founding investors ...
Series A co-led by Abingworth, DaVita Venture Group, and F-Prime with participation from Curie.Bio, SymBiosis, and U.S. Renal CarePartnership with Alebund Pharmaceuticals to gain exclusive global ...
One day not long ago, a founder texted his investor with an update: he was replacing his entire customer service team with Claude Code, an AI tool that can write and deploy software on its own. To Lex ...
This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. The round is led by F-Prime with participation from The Treasury, ...
MINNEAPOLIS, Nov. 11, 2025 /PRNewswire/ -- iRiva Medical, Inc., a privately held, development stage medical device company based in Minneapolis, and NuXcel spinoff, announced the closing of its ...
Abstract: Traditional component-based frameworks (CBFs), such as NASA’s F Prime, promote modularity and reuse but lack native support for formal verification, limiting their applicability in ...
Default queue implementations do not support ISR usage (locks) Time throttling of Events is not supported in ISR context (locks) Throttled events are only supported on platforms with lock-free atomic ...
People wearing suits entering Pfizer’s building in New York City. People enter Pfizer’s headquarters in New York City. Credit: AP/ Yuki Iwamura After abandoning the development of an oral weight-loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results